Sex Differences in Modifiable Risk Factors and Severity of Coronary Artery Disease

Olivia Manfrini1, Jinsung Yoon2, Mihaela van der Schaar3

  • 1Department of Experimental, Diagnostic and Specialty Medicine University of Bologna Bologna Italy.

Insights

Traditional risk factors like smoking and diabetes disproportionately increase obstructive coronary artery disease (CAD) risk in women. Obstructive CAD in women indicates a higher mortality risk compared to men, necessitating targeted interventions.

Area of Science:

  • Cardiology
  • Public Health
  • Sex-Specific Medicine

Background:

  • The sex-specific impact of traditional risk factors on coronary artery disease (CAD) burden remains unclear.
  • Understanding these differences is crucial for effective cardiovascular disease prevention and treatment strategies.

Purpose of the Study:

  • To investigate the sex-specific associations between traditional risk factors and the severity of CAD.
  • To examine the relationship between CAD severity, traditional risk factors, and 30-day mortality in a sex-specific manner.

Main Methods:

  • Analysis of 14,793 patients from the ISACS-TC registry who underwent coronary angiography for acute coronary syndromes (2010-2019).
  • Calculation of relative risk (RR) ratios for obstructive versus nonobstructive CAD, comparing women to men using inverse probability weighting.
  • Assessment of interactions between diabetes mellitus, smoking status, hypercholesterolemia, hypertension, and sex on CAD severity and mortality.

Main Results:

  • Diabetes mellitus and current smoking showed significant sex-specific interactions, disproportionately increasing the risk of obstructive CAD in women (P=0.002 for diabetes, P=0.018 for smoking).
  • Women with obstructive CAD had significantly higher 30-day mortality rates compared to men (RR, 1.75; 95% CI, 1.48-2.07).
  • No significant sex differences in mortality were observed in patients with nonobstructive CAD.

Conclusions:

  • Obstructive CAD in women is associated with a higher mortality risk than in men.
  • Diabetes and smoking exacerbate obstructive CAD risk more significantly in women, highlighting the need for tailored interventions.
  • Intensified lifestyle and treatment interventions are essential for improving cardiovascular health outcomes in women.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
719
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
505
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
245
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
212
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
235
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
223